Human Disease News
-
Cost-effective Animal Disease Models to Power Up Life Science Research
In a pioneering effort to revolutionize life science research, a wide range of cost-effective animal disease models, from Drosophila to non-human primates, from knockout models to different disease models, are released. These groundbreaking models are set to empower researchers worldwide by enabling them to unravel the mysteries of various diseases more efficiently and affordably than ever ...
By Protheragen
-
Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing
Creative Enzymes, a leading global supplier and manufacturer of quality enzymes, is thrilled to introduce the availability of Recombinant Homocysteine Methyltransferase, dedicated to assisting researchers and industrial clients to unravel the complexity of enzyme activity. Originated from Pichia pastoris, the Homocysteine Methyltransferase, Recombinant has raised the bar in the field of ...
-
Multi-Type Animal Cognitive Behavioral Tests for Disease Research
In the pursuit of advancing disease research and its treatment, animal cognitive behavior is studied in a wide range of animal species. The innovative multi-type animal cognitive behavioral tests are set to complement disease research methodology, enabling scientists to gain deeper insight into the complexities of cognitive functioning and its implications in various pathological conditions. ...
By Protheragen
-
Creative Proteomics Launches Innovative Yeast Untargeted Lipidomics Service
Creative Proteomics, a leading provider of proteomics and metabolomics services, has announced the launch of its highly anticipated Yeast Untargeted Lipidomics service. This groundbreaking service is poised to revolutionize yeast lipid research by offering comprehensive and high-throughput analysis of lipids in yeast samples. Yeast, widely recognized as a model organism, plays a pivotal role in ...
-
CD Genomics’ RNA-Solutions Platform Now Supports Exosomal RNA Research
CD Genomics’ RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Based on rich RNA project experience and leading bioinformatics analytical capabilities, CD Genomics has launched a systematic solution for exosomal RNA research that assists in in-depth identification and functional analysis of exosomal ...
By CD Genomics
-
CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service
CD Genomics is a leading global life sciences company committed to providing the research community with high-quality long-read sequencing services, from Oxford Nanopore to PacBio SMRT sequencing. The Product Manager of the Long-Read Sequencing Division announced the launch of the Human Leukocyte Antigen (HLA) Typing service to support high-resolution HLA typing in a rapid and cost-efficient ...
By CD Genomics
-
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS). The program involved using Oxford Nanopore’s ...
-
CytoRecovery Awarded National Science Foundation Phase II SBIR Research Grant
CytoRecovery, Inc., a leader in marker free technologies for the enrichment, sorting, and recovery of live cells, announced today that the National Science Foundation (NSF) has approved its application to receive a Phase II SBIR Research Grant. Titled “Bioelectrical Cell Enrichment, Sorting, and Recovery with On-Chip Sample Prep and Monitoring,” the grant will provide $952,558 in ...
-
(Viral) Vaccine Manufacturing
It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...
By Nuvonis
-
Roswell Biotechnologies Forms Scientific Advisory Board
Roswell Biotechnologies, Inc., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will be instrumental in the final stages of development and commercialization of the company's molecular electronics chip, a fully scalable universal biosensor capable of seeing ...
-
New partnership to advance glycoproteomics and biotherapeutics tools and research
Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today a new partnership to advance glycoproteomics and biotherapeutics tools and research Macquarie University’s Analytical Glycoimmunology Group and Protein Metrics Inc. today have launched a strategic partnership scheme to further advance glycoproteomics and biotherapeutics ...
-
HemoShear Therapeutics to Participate in Piper Sandler Healthcare Conference
HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, today announced that Brain Wamhoff, Interim CEO, will present at the 34th Annual Piper Sandler Healthcare Conference being held November 29 – December 1 in New York City. The HemoShear management team will also participate in one-on-one meetings with investors. Meetings may be requested through Piper ...
-
HemoShear Therapeutics to Participate in SVB Leerink Securities Biopharma Private Company Connect
HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, today announced that it will participate in SVB Leerink Biopharma Private Company Connect being held virtually October 26-27. Investor one-on-one meetings with the HemoShear management team may be requested through SVB Securities. About HemoShear Therapeutics HemoShear Therapeutics, Inc. is a privately held ...
-
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
-
Introduction to DNA Methylation Analysis: From Wet Lab Experiments to Bioinformatics Analysis
Methylation is one of the most classical epigenetic modifications in eukaryotes. DNA methylation regulates gene expression and has important implications in both growth and disease-related research. DNA methylation affects the maturation of germ cells or embryonic cells subject to specific gene expression. It has also been widely studied and applied to track aging and various forms of human ...
By CD Genomics
-
Myrtelle and Forge Biologics Announce Viral Vector and Plasmid DNA cGMP Manufacturing Partnership
Myrtelle Inc., (Myrtelle), a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced a manufacturing partnership that will advance Myrtelle’s novel gene therapy for monogenic hearing loss, Myr-201, into clinical trials ...
-
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
Metabolomics, a subdivision of Creative Proteomics, is dedicated to providing metabolomics services based on cutting-edge LC-MS technology for biomedical research institutions, biotechnology companies, and pharmaceutical companies. Creative Proteomics has developed highly sensitive, selective and accurate LC/MS/MS analytical solutions for the identification and quantification of vitamins in ...
-
Redox Check-Up
A new Service for the Medical Practice Reactive Oxygen Species (ROS) represent one of the most abundant types of free radicals. In physiological conditions ROS levels are regulated by a fine equilibrium namely RedOx balance. When ROS production outperforms the physiological ability to counteract the deleterious effects of these reactive species a condition known as oxidative stress (OS) ...
By H & D S.r.l.
-
Creative Biogene Releases Comprehensive Mitochondrial Gene Expression Services
Creative Biogene today released comprehensive mitochondrial gene expression services with streamlined project procedures and high-standard mtDNA expression results. "For years, we have been engaged in the mitochondrial study. Our scientists explore mitochondrial gene expression via mtDNA microarray expression profiling, gene chip data mining, key gene & protein verification, and functional ...
-
HemoShear Develops New Human Tissue-Based Model of Rare Liver Disease Under Research Collaboration with Takeda
HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has received a milestone payment under its October 2020 research collaboration and service agreement with Takeda. The milestone acknowledges development of a human tissue-based model of an undisclosed rare liver disease using the company’s REVEAL-Tx™ platform. REVEAL-Tx™ combines physiological ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you